Page last updated: 2024-10-25

clonidine and Striatonigral Atrophy

clonidine has been researched along with Striatonigral Atrophy in 1 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Research Excerpts

ExcerptRelevanceReference
"Multiple System Atrophy (MSA) and idiopathic Parkinson's disease (PD) can be difficult to distinguish."1.31Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration. ( Horstink, MW; Lenders, JW; Oyen, WJ; Strijks, E; Sweep, F; van't Hof, M, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strijks, E1
van't Hof, M1
Sweep, F1
Lenders, JW1
Oyen, WJ1
Horstink, MW1

Other Studies

1 other study available for clonidine and Striatonigral Atrophy

ArticleYear
Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Journal of neurology, 2002, Volume: 249, Issue:9

    Topics: Aged; Analysis of Variance; Chi-Square Distribution; Clonidine; Diagnosis, Differential; Growth Horm

2002